Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells
Lynsey A. McHugh, A. Emre Sayan, Jakob Mejlvang, T. R.Leyshon Griffiths, Yiyang Sun, Margaret M. Manson, Eugene Tulchinsky, J. Kilian Mellon, Marina Kriajevska
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells'. Together they form a unique fingerprint.